Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Jennifer Dotson to Treatment Outcome

This is a "connection" page, showing publications Jennifer Dotson has written about Treatment Outcome.

 
Connection Strength
  
 
 
0.213
  
  1. Dotson JL, Crandall W, Mousa H, Honegger JR, Denson L, Samson C, Cunningham D, Balint J, Dienhart M, Jaggi P, Carvalho R. Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: a case series. Inflamm Bowel Dis. 2011 Jan; 17(1):56-61.
    View in: PubMed
    Score: 0.042
  2. Davidson N, Morris GA, Wright MA, Brock G, Boyle B, Dotson JL, Michel HK, Maltz RM. Predictors of antitumor necrosis factor primary nonresponse and drug durability in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2025 Oct; 81(4):1024-1033.
    View in: PubMed
    Score: 0.029
  3. Wright JC, Ardura MI, Dotson JL, Boyle B, Maltz RM, Michel HK. Management and outcomes of histoplasmosis in youth with inflammatory bowel disease in an endemic area. J Pediatr Gastroenterol Nutr. 2024 Dec; 79(6):1153-1163.
    View in: PubMed
    Score: 0.027
  4. McNicol M, Abdel-Rasoul M, McClinchie MG, Morris GA, Boyle B, Dotson JL, Michel HK, Maltz RM. Clinical outcomes and cost savings of a nonmedical switch to a biosimilar in children/young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2024 03; 78(3):644-652.
    View in: PubMed
    Score: 0.026
  5. Rowland P, McNicol M, Kiel A, Maltz RM, Donegan A, Dotson JL, Michel HK, Boyle B. Proactive therapeutic drug monitoring and vedolizumab dose optimization in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2024 Apr; 78(4):853-861.
    View in: PubMed
    Score: 0.026
  6. Serpico MR, Maltz R, Crandall W, Bricker J, Dotson JL, Kim SC, Boyle B. Thiopurine Optimization Through Combination With Allopurinol in Children With Inflammatory Bowel Diseases. J Pediatr Gastroenterol Nutr. 2018 09; 67(3):341-345.
    View in: PubMed
    Score: 0.018
  7. Shaikhkhalil AK, Boyle B, Smith J, Dotson JL, Donegan A, Kim SC, Maltz RM, Crandall W. Using Quality Improvement to Increase Utilization of Enteral Therapy in Pediatric Crohn Disease: Results and Outcomes. J Pediatr Gastroenterol Nutr. 2018 Jun; 66(6):909-914.
    View in: PubMed
    Score: 0.017
  8. Huntington JT, Boomer LA, Pepper VK, Diefenbach KA, Dotson JL, Nwomeh BC. Minimally Invasive Ileal Pouch-Anal Anastomosis with Rectal Eversion Allows for Equivalent Outcomes in Continence in Pediatric Patients. J Laparoendosc Adv Surg Tech A. 2016 Mar; 26(3):222-5.
    View in: PubMed
    Score: 0.015
  9. Vergidis P, Avery RK, Wheat LJ, Dotson JL, Assi MA, Antoun SA, Hamoud KA, Burdette SD, Freifeld AG, McKinsey DS, Money ME, Myint T, Andes DR, Hoey CA, Kaul DA, Dickter JK, Liebers DE, Miller RA, Muth WE, Prakash V, Steiner FT, Walker RC, Hage CA. Histoplasmosis complicating tumor necrosis factor-a blocker therapy: a retrospective analysis of 98 cases. Clin Infect Dis. 2015 Aug 01; 61(3):409-17.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.